Business R&D investment set to grow by 5 per cent for next three years

Research by the European Union's Joint Research Centre (JRC) suggests that business investment in research and development (R&D) will increase by as much as five per cent per year for the next three years.

Increasing R&D investment is a key component of the Lisbon Strategy, and the blueprint for European innovation. The expert group report chaired by former Finnish Prime Minister Esko Aho explicitly refers to the Lisbon goal of increasing investment in research to three per cent of GDP. In 2005, only 1.91 per cent of GDP was spent on R&D in the EU.

Should this increase be mirrored across the board, then the figure could rise to almost 2.2 per cent of GDP spent on R&D by 2010 - short of Lisbon targets but still a huge improvement.

The European Commission's Seventh Framework Programme (FP7) will see huge increases in its budget compared to previous Framework Programmes. This money will go directly to research, but money also has to come from business. "If we are to reach our objective of investing 3 per cent of GDP in research and development, we need increased investment by the private sector," said European Commissioner for Science and Research, Janez Potocnik.

"For this reason the results of this survey are encouraging. We need to maintain and reinforce our efforts at European and national level to make Europe an attractive place for companies to carry out their research. The Commission will be coming forward with some more ideas in this area in autumn 2006," continued the Commissioner.

Perhaps unsurprisingly, companies prefer to invest in their own countries. The largest investors in R&D continue to be the largest economies - Germany, France and the UK. However, the skill of workforce and access to markets were found by the report to be significant factors. Meanwhile, cost of workforce was low. For EU companies, the US is the most attractive non-EU state to invest, followed by India and China.

Perhaps more importantly, "The incentives to increase R&D investment most often cited in the responses are: changes in market demand for new products and services, changes in technological opportunities, and changes in company turnover or profit. Changes in the availability and labour costs of researchers are the least often cited incentives for increasing R&D investment," reads the report.

This shows that companies are pragmatic, and respond to market and economic need. This also demonstrates the importance of developing lead markets for technological innovations, to encourage further research, as cited in the expert group report into innovation.

The survey questioned 449 firms in ten sectors: automobiles and parts; chemicals; electronic and electrical equipment; engineering and machinery; food producers and processors; health; IT hardware; pharmaceuticals and biotechnology; steel and other metals; and support services

For further information, please visit the European Commission's innovation portal and read the expert group report:
http://ec.europa.eu/invest-in-research/index_en.htm

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...